Introduction/Background Ultra-staging with immunohistochemistry (IHC) increases the detection of sentinel lymph node metastasis in endometrial cancer. The aims of this study were:
To determine the percentage of positive SLN identified on ultra-staging with IHC which were negative on H&E.
To determine if the ultra-staging/IHC result altered the prescription of adjuvant therapy.
Methodology 120 women with histologically confirmed endometrial cancer, treated with a minimally invasive hysterectomy, BSO and SLN mapping were included. All mapped SLNs were histopathological confirmed. If no macroscopic metastasis were identified on H&E staining, ultra-staging with IHC was performed.
Results SLNs of 103 patients were included in the histopathological analysis. Ninety eight percent (101/103) of all, had ultra-staging performed. Positive SLNs were identified in 7 cases. Two cases had macroscopic metastasis on H&E staining. Using our ultra-staging protocol, 5 patients (5%) had positive SLNs (3 had microscopic metastasis and 2 had isolated tumour cells). According to the Queensland Centre for Gynaecological Cancer (QCGC) protocol for adjuvant therapy, 14 of 101 patients (14%) had their adjuvant treatment altered based on the SLN status after ultra-staging.
Conclusion Ultra-staging with IHC increased the detection of positive SLNs. Ultra-staging decreased the prescribed adjuvant therapy in 14% of our patients.
Disclosure Nothing to disclose.
Statistics from Altmetric.com
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.